IP
Ishari P. Shrestha
EVP, Head of Research & Development, Executive Lead-HR, Co-Founder
i3 PharmaceuticalsTherapeutic Areas
i3 Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Methscopolamine Bromide Tablets | Not Specified (Typically GI/Respiratory) | Approved |
| Clindamycin Phosphate Topical Solution | Bacterial Infection | Approved |
| Posaconazole DR Tablets | Fungal Infection | Approved |
| Maraviroc Tablets | HIV Infection | Approved |
| Guanfacine Tablets | ADHD / Hypertension | Approved |
| Isosorbide Dinitrate/Hydralazine HCl Tablets | Heart Failure | Approved |